Arcutis Biotherapeutics SEC filings

Filter: All · 8-K · 10-Q · 10-K · Form 4

4Oct. 28, 2026, 4:20 p.m. ETView on SEC.gov
8-KOct. 28, 2026, 9:04 a.m. ETView on SEC.gov
Departure/appointment of directors or officers · Regulation FD disclosure · Financial statements and exhibits
AI summary, unreviewedArcutis Biotherapeutics Appoints Dr. Robert Scott, Former AbbVie CMO, to Board of Directors
4Oct. 19, 2026, 4:49 p.m. ETView on SEC.gov
SCHEDULE 13G/AOct. 5, 2026, 11:58 a.m. ETView on SEC.gov
4Sept. 18, 2026, 4:17 p.m. ETView on SEC.gov
4Sept. 17, 2026, 4:06 p.m. ETView on SEC.gov
4Sept. 10, 2026, 7:24 p.m. ETView on SEC.gov
4Aug. 28, 2026, 5:40 p.m. ETView on SEC.gov
4Aug. 24, 2026, 4:19 p.m. ETView on SEC.gov
4Aug. 21, 2026, 4:08 p.m. ETView on SEC.gov
4Aug. 19, 2026, 4:57 p.m. ETView on SEC.gov
SCHEDULE 13GAug. 14, 2026, 6:20 a.m. ETView on SEC.gov
4Aug. 13, 2026, 8:06 p.m. ETView on SEC.gov
SCHEDULE 13GAug. 7, 2026, 8:42 a.m. ETView on SEC.gov
10-QAug. 5, 2026, 4:21 p.m. ETView on SEC.gov
8-KAug. 5, 2026, 4:14 p.m. ETView on SEC.gov
Results of operations and financial condition · Departure/appointment of directors or officers · Financial statements and exhibits
4Aug. 5, 2026, 9:42 p.m. ETView on SEC.gov
4Aug. 5, 2026, 9:42 p.m. ETView on SEC.gov
4Aug. 5, 2026, 9:42 p.m. ETView on SEC.gov